Single-Ascending-Dose Pharmacokinetic Study of Tribendimidine in Opisthorchis viverrini-Infected Patients

Praziquantel is the only drug available for the treatment of Opisthorchis viverrini infections. Tribendimidine has emerged as a potential treatment alternative; however, its pharmacokinetic (PK) properties have not been sufficiently studied to date. Via two phase IIa dose-finding studies, 68 O. vive...

Descripción completa

Detalles Bibliográficos
Autores principales: Duthaler, Urs, Sayasone, Somphou, Vanobbergen, Fiona, Penny, Melissa A., Odermatt, Peter, Huwyler, Jörg, Keiser, Jennifer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2016
Materias:
Experimental Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5038241/
https://www.ncbi.nlm.nih.gov/pubmed/27431234
http://dx.doi.org/10.1128/AAC.00992-16

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5038241/
https://www.ncbi.nlm.nih.gov/pubmed/27431234
http://dx.doi.org/10.1128/AAC.00992-16

Ejemplares similares